NU-VERAP SR TABLET (EXTENDED-RELEASE) Канада - англійська - Health Canada

nu-verap sr tablet (extended-release)

nu-pharm inc - verapamil hydrochloride - tablet (extended-release) - 120mg - verapamil hydrochloride 120mg - miscellaneous calcium-channel blocking agents

PREZCOBIX TABLET Канада - англійська - Health Canada

prezcobix tablet

janssen inc - darunavir (darunavir ethanolate); cobicistat - tablet - 800mg; 150mg - darunavir (darunavir ethanolate) 800mg; cobicistat 150mg - hiv protease inhibitors

TECHNIVIE TABLET Канада - англійська - Health Canada

technivie tablet

abbvie corporation - ombitasvir; paritaprevir; ritonavir - tablet - 12.5mg; 75mg; 50mg - ombitasvir 12.5mg; paritaprevir 75mg; ritonavir 50mg - hcv protease inhibitors

MYLAN-VERAPAMIL SR TABLET (EXTENDED-RELEASE) Канада - англійська - Health Canada

mylan-verapamil sr tablet (extended-release)

mylan pharmaceuticals ulc - verapamil hydrochloride - tablet (extended-release) - 120mg - verapamil hydrochloride 120mg - miscellaneous calcium-channel blocking agents

ATRIPLA- efavirenz, emtricitabine, and tenofovir disoproxil fumarate tablet, film coated США - англійська - NLM (National Library of Medicine)

atripla- efavirenz, emtricitabine, and tenofovir disoproxil fumarate tablet, film coated

a-s medication solutions - efavirenz (unii: je6h2o27p8) (efavirenz - unii:je6h2o27p8), emtricitabine (unii: g70b4etf4s) (emtricitabine - unii:g70b4etf4s), tenofovir disoproxil fumarate (unii: ott9j7900i) (tenofovir anhydrous - unii:w4hfe001u5) - efavirenz 600 mg - atripla® is indicated for use alone as a complete regimen or in combination with other antiretroviral agents for the treatment of hiv-1 infection in adults and pediatric patients 12 years of age and older. atripla is contraindicated in patients with previously demonstrated clinically significant hypersensitivity (e.g., stevens-johnson syndrome, erythema multiforme, or toxic skin eruptions) to efavirenz, a component of atripla. coadminstration of atripla with voriconazole is contraindicated. efavirenz, a component of atripla, significantly decreases voriconazole plasma concentrations, and coadministration may decrease the therapeutic effectiveness of voriconazole. also, voriconazole significantly increases efavirenz plasma concentrations, which may increase the risk of efavirenz-associated side effects. because atripla is a fixed-dose combination product, the dose of efavirenz cannot be altered [see clinical pharmacology (12.3) tables 4 and 5]. pregnancy category d [see warnings and precautions (5.9)] antiret

SYMTUZA TABLET Канада - англійська - Health Canada

symtuza tablet

janssen inc - darunavir (darunavir ethanolate); cobicistat; emtricitabine; tenofovir alafenamide (tenofovir alafenamide hemifumarate) - tablet - 800mg; 150mg; 200mg; 10mg - darunavir (darunavir ethanolate) 800mg; cobicistat 150mg; emtricitabine 200mg; tenofovir alafenamide (tenofovir alafenamide hemifumarate) 10mg - antiretrovirals

PMS-EFAVIRENZ-EMTRICITABINE-TENOFOVIR TABLET Канада - англійська - Health Canada

pms-efavirenz-emtricitabine-tenofovir tablet

pharmascience inc - efavirenz; emtricitabine; tenofovir disoproxil fumarate - tablet - 600mg; 200mg; 300mg - efavirenz 600mg; emtricitabine 200mg; tenofovir disoproxil fumarate 300mg - nonnucleoside reverse transcriptase inhibitors

MYLAN-DARUNAVIR TABLET Канада - англійська - Health Canada

mylan-darunavir tablet

mylan pharmaceuticals ulc - darunavir - tablet - 75mg - darunavir 75mg - hiv protease inhibitors

MYLAN-DARUNAVIR TABLET Канада - англійська - Health Canada

mylan-darunavir tablet

mylan pharmaceuticals ulc - darunavir - tablet - 150mg - darunavir 150mg - hiv protease inhibitors

MYLAN-DARUNAVIR TABLET Канада - англійська - Health Canada

mylan-darunavir tablet

mylan pharmaceuticals ulc - darunavir - tablet - 300mg - darunavir 300mg - hiv protease inhibitors